Vanguard Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $288M | Buy |
|
|||||
|
2023
Q1 | $250M | Buy |
|
|||||
|
2022
Q4 | $103M | Buy |
|
|||||
|
2022
Q3 | $66.7M | Buy |
|
|||||
|
2022
Q2 | $79.6M | Sell |
|
|||||
|
2022
Q1 | $86.6M | Buy |
|
|||||
|
2021
Q4 | $67.4M | Buy |
|
|||||
|
2021
Q3 | $256M | Buy |
|
|||||
|
2021
Q2 | $359M | Buy |
|
|||||
|
2021
Q1 | $243M | Buy |
|
|||||
|
2020
Q4 | $287M | Buy |
|
|||||
|
2020
Q3 | $206M | Sell |
|
|||||
|
2020
Q2 | $344M | Sell |
|
|||||
|
2020
Q1 | $323M | Buy |
|
|||||
|
2019
Q4 | $443M | Buy |
|
|||||
|
2019
Q3 | $147M | Buy |
|
|||||
|
2019
Q2 | $165M | Buy |
|
|||||
|
2019
Q1 | $144M | Buy |
|
|||||
|
2018
Q4 | $70.6M | Buy |
|
|||||
|
2018
Q3 | $97.1M | Buy |
|
|||||
|
2018
Q2 | $23.7M | Buy |
|
|||||
|
2018
Q1 | $12.8M | Buy |
|
|||||
|
2017
Q4 | $17.3M | Buy |
|
|||||
|
2017
Q3 | $16.1M | Buy |
|
|||||
|
2017
Q2 | $9.35M | Buy |
|
|||||
|
2017
Q1 | $3.19M | Sell |
|
|||||
|
2016
Q4 | $3.12M | Buy |
|
|||||
|
2016
Q3 | $3.36M | Buy |
|
|||||
|
2016
Q2 | $946K | Buy |
|